View this email in your browser.

Financial advisors appointed as options considered for future ownership and growth of renowned cava and still wine group

Financial advisors appointed as options considered for future ownership and growth of renowned cava and still wine group

Key takeaways Harvey Schwartz, de CEO van Carlyle Group, is van mening dat zorgen over de nationale veiligheid een enorme groeikans in de industriële en defensiesectoren stimuleren. Tijdens de Bernstein Strategic Decisions Conference in New York merkte Schwartz op dat de wereldwijde discussies momenteel worden gedomineerd door veiligheidskwesties. Hij schreef deze verschuiving toe aan het […]

Key takeaways Als gevolg van sancties door de Russische acties in Oekraïne heeft Lukoil, de op één na grootste olieproducent van Rusland, ingestemd met de verkoop van het grootste deel van zijn internationale activa, met een waarde van ongeveer 22 miljard dollar (ongeveer 18,4 miljard euro), aan de Amerikaanse private-equityfirma Carlyle Group. De overeenkomst is […]

Carlyle Group (CG) agreed on Apr 5, 2026 to buy a majority stake in MAI Capital at a $2.8B valuation, signaling a tilt toward control-oriented private-equity deals.

BMO's Apr 3, 2026 note cited rising BDC redemptions and credit strain; the move forced a re‑rating of Carlyle (CG) and highlighted liquidity risks in private credit.

Donald Trump’s choice to lead the Federal Reserve has a big plan for the central bank. It comes with a lot of risk.

Years after the Obama administration's EPA adjusted its renewable energy laws to favor the refinery owned by private equity firm Carlyle Group, the former president made a stop at the company's recent...

Carlyle overhauls top leadership, appointing John Redett, Mark Jenkins, and Jeff Nedelman as co-presidents effective January 2026 to drive strategic expansion. A New Era Begins at Carlyle with Co-Pres...

Fund will be used alongside private sector to invest in infrastructure

A penetrating look at the company at the nexus of big business, government, and defense

A dozen companies in which Carlyle had a controlling interest netted more than $9.3 billion in contracts. Overall, six private investment firms, including Carlyle, received nearly $14 billion in Penta...

By Isla Binnie and Niket Nishant (Reuters) -Carlyle Group reported a better-than-expected profit in the second quarter on Wednesday, helped by a pickup in fees as it grew its assets under management. Its CEO Harvey Schwartz has been working on a turnaround after a few difficult years linked to an industry-wide downturn and an internal succession struggle. Schwartz identified wealth, global credit and insurance and capital markets among priorities when he took over in 2023. Last week, Carlyle named three of its longtime insiders as co-presidents, a new role and a step some analysts said could help reinforce investors’ confidence in the company. Distributable earnings, or profit that can be returned to shareholders, jumped 25.6% to $431 million, or 91 cents per share. That compares with 89 cents that analysts had expected, according to estimates compiled by LSEG. Fee-related earnings grew 18.4% to $323.3 million in the quarter. Fund management fees rose 16% and transaction and portfolio advisory fees, which Carlyle earns from arranging capital market deals for its portfolio companies and other clients, jumped 66%. Assets under management at the Washington, D.C.-based company rose 7% to $465 billion, thanks to growth in Carlyle AlpInvest, the unit for second-hand private equity funds that Schwartz has also made a priority. The secondary market has given pension funds and other private equity investors a way to sell stakes in companies at a time when elevated interest rates, sweeping U.S. tariffs and geopolitical uncertainty have hampered dealmaking. Still, market activity was accelerating, Schwartz said. The company generated $13.4 billion of fresh capital. It deployed $14.6 billion and had $89 billion available for investment at the end of the quarter. Nasdaq composite index. Its shares were up nearly 2% in thin trading before the open. With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Sure, there are always opportunities in the stock market – but finding them feels more difficult now than a year ago. Unsure where to invest next? One of the best ways to discover new high-potential opportunities is to look at the top performing portfolios this year. ProPicks AI offers 6 model portfolios from Investing.com which identify the best stocks for investors to buy right now. For example, ProPicks AI found 9 overlooked stocks that jumped over 25% this year alone. The new stocks that made the monthly cut could yield enormous returns in the coming years. Is CG one of them?

Investing.com -- Private equity firm Carlyle Group (NASDAQ:CG) is preparing to sell up to a 10% stake in India’s Piramal Pharma, according to a report from Moneycontrol on Thursday. The U.S.-based firm could earn between 26 billion rupees ($304.8 million) and 27 billion rupees from the sale, which would be conducted through block trades, the report said, citing sources. As of March-end this year, Carlyle Group, through its affiliate Ca Alchemy Investments, held an 18% stake in Piramal Pharma, according to exchange data. The private equity firm had originally acquired a 20% stake in the Indian drugmaker in 2020 for approximately $490 million, the Moneycontrol report added. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

(Reuters) -Private equity firm Carlyle Group (NASDAQ:CG) is preparing to offload up to a 10% stake in India’s Piramal Pharma, online news portal Moneycontrol reported on Thursday, citing sources. The U.S.-based firm could earn in the range of 26 billion rupees ($304.8 million) to 27 billion rupees from the sale via block trades, the report added. Carlyle Group and Piramal Pharma did not immediately respond to Reuters requests for comment. Carlyle Group, through its affiliate Ca Alchemy Investments, had a 18% stake in Piramal Pharma as of March-end this year, exchange data showed. ($1 = 85.3090 Indian rupees)

Investing.com - JMP Securities maintained its Market Outperform rating on The Carlyle Group LP (NASDAQ:CG) with a price target of $58.00 on Tuesday. The research firm increased its 2025 earnings per share estimate to $4.22 from the previous forecast of $4.05, while keeping its 2026 earnings per share estimate unchanged at $4.75. JMP analyst Brian McKenna stated, "We increase our 2025E EPS to $4.22 from $4.05 and make no change to our 2026E EPS of $4.75. Our $58 price target reflects an ~12.0x multiple on our 2026E EPS." The $58 price target represents JMP’s valuation of Carlyle Group based on approximately 12 times the firm’s estimated 2026 earnings per share. The private equity firm’s stock rating reaffirmation comes as Carlyle continues to manage its global portfolio of investments across various sectors including private equity, real assets, and investment solutions. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C. Which stock should you buy in your very next trade? With valuations skyrocketing in 2024, many investors are uneasy putting more money into stocks. Unsure where to invest next? Get access to our proven portfolios and discover high-potential opportunities. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. That's an impressive track record. With portfolios tailored for Dow stocks, S&P stocks, Tech stocks, and Mid Cap stocks, you can explore various wealth-building strategies.

(Reuters) -Insurance brokerage firm Trucordia received a $1.3 billion strategic investment from global investment firm Carlyle, valuing the company at more than $5.7 billion, it said on Wednesday. The investment is expected to reduce Trucordia’s leverage and simplify its governance structure by repurchasing units from existing minority investors. The U.S.-based brokerage offers commercial and personal insurance, life insurance, and employee benefits solutions. J.P. Morgan acted as financial advisor to Trucordia.

NEW YORK (Reuters) -AlpInvest Partners has raised $4.1 billion for its ninth co-investment fund, an executive at the unit of private equity group Carlyle said, showing continued appetite among investors for access to buyout firms’ dealmaking. The size of AlpInvest Co-Investment Fund IX (ACF IX), and related strategies, exceeds the $3.5 billion eighth iteration of the fund raised in 2021. Richard Dunne, who leads AlpInvest’s co-investment team alongside Roberto Torrini, said the firm’s success in raising an enlarged fund came from securing strong support from previous investors but also inflows from new investors wanting exposure to private equity buyouts. "Part of our value proposition is giving investors access to a part of the market that we believe is incredibly difficult for them to replicate," Dunne said in an interview. Co-investors join with buyout firms to provide the capital needed to fund an acquisition. As co-invest opportunities are restricted to a few parties on each deal, co-investment funds allow numerous financiers to gain access at the same time - opening the door for smaller, or newer, money managers to participate, as well as the largest institutional investors. AlpInvest began raising ACF IX in 2023, and ultimately drew contributions from 185 global investors, including pension funds, asset managers and family offices. The extended timeframe for the raise helped draw in additional new backers, Dunne said. "For newer investors to the asset class, we believe we are a compelling option for them, so staying open for longer is always a good idea and that helped drive us to the finish." ACF IX will invest in whole-company buyout transactions as well as stake purchases, across industry sectors globally. Dunne said among the best investments for ACF IX are backing middle-market transactions, as private equity firms are making good acquisitions in this part of the market, at prices roughly a 15% to 20% discount to what similar assets would have cost during the peak buyout years at the start of the decade. AlpInvest has committed upwards of $19 billion across more than 400 equity co-investments over the past 25 years. The money manager’s broader platform includes strategies which buy stakes in other private equity funds, and provide financing to the buyout industry. Should you invest $2,000 in CG right now? ProPicks AI are 6 model portfolios created by Investing.com which identify the best stocks for investors to buy now. The stocks that made the cut could produce monster returns in the coming years. Is CG one of them?